跳至主要内容
临床试验/NL-OMON38245
NL-OMON38245已完成4 期

Maraviroc Abacavir STudy - effect on Endothelial Recovery - MASTER

niversitair Medisch Centrum Utrecht0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Age > 18 years
  • -HIV-1 infection
  • -Treatment with antiretroviral regimen containing abacavir for at least the previous 3 months
  • -Undetectable plasma HIV RNA (50 cp/ml) for at least 6 months (one *blip* allowed, which is defined as a detectable plasma HIV-RNA level between 50 and 400 copies/ml, preceded and followed by undetectable (<50 copies/ml) plasma HIV-RNA measurements)
  • -CD4+ cell count > 200 cells/µL
  • -Signed informed consent

排除标准

  • -Pregnancy
  • -Breastfeeding
  • -Allergy for peanuts or soya
  • -Hypersensitivity for maraviroc
  • -Treatment of underlying malignancy
  • -Acute infection in the preceding 30 days
  • -Renal insufficiency requiring hemodialysis
  • -Acute or decompensated chronic hepatitis
  • -Modification of antiretroviral regimen in the previous 3 months

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验